Researchers Uncover Brain Activity Linking Nicotine Withdrawal to Pain Sensitivity

Research has revealed that smokers who abstain from nicotine experience heightened pain sensitivity, particularly during withdrawal. A study published in the Journal of Neuroscience on November 7, 2025, by a team led by Zhijie Lu from Fudan University Minhang Hospital and Kai Wei from Shanghai Eastern Hepatobiliary Surgery Hospital, examined the connections between nicotine withdrawal and increased pain sensitivity.

The study involved 30 abstinent smokers and 30 nonsmokers. It found that those who had recently stopped smoking exhibited altered brain activity, which correlated with a significant increase in their sensitivity to pain. This heightened sensitivity led to a greater demand for postoperative analgesics, particularly opioids, compared to their nonsmoking counterparts.

As the duration of abstinence from nicotine increased, so did the pain sensitivity experienced by the participants. The research indicated that specific brain regions were particularly involved in this phenomenon. Importantly, the study noted that pain sensitivity may normalize after a period of abstinence exceeding three months.

According to Kai Wei, “Our study does not discourage smokers from quitting before surgery. Our aim is to encourage researchers to delve deeper into the mechanisms underlying elevated pain sensitivity during short-term abstinence.” The findings highlight the clinical challenge faced by healthcare providers in managing pain for individuals who have recently quit smoking.

The research team identified two distinct sets of brain regions associated with the relationship between the need for postoperative pain relief and withdrawal symptoms. This suggests that understanding these mechanisms could lead to more effective pain management strategies for abstinent smokers.

As part of their ongoing investigation, the researchers are exploring alternatives to opioids that may provide effective pain relief for abstinent smokers. They are also examining the mechanisms and effectiveness of preoperative nicotine replacement therapies, which could potentially ease withdrawal symptoms and improve pain management outcomes.

The significance of these findings extends beyond individual patients. Addressing the increased analgesic needs of abstinent smokers can help reduce the risks associated with opioid use, contributing to safer postoperative care practices.

The study underscores the importance of further research into the brain’s response to nicotine withdrawal and its implications for pain management, ultimately aiming to enhance the quality of care for patients undergoing surgery.